Newer Imaging Modalities to Assist With Target Localization in the Radiation Treatment of Prostate Cancer and Possible Lymph Node Metastases

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 1 SUPPL., 2008, Pages

  John, Subhash S ^a   Zietman, Anthony L ^a   Shipley, William U ^a   Harisinghani, Mukesh G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical target volume; Imaging; Prostate cancer

Indexed keywords

FLUORINE COMPOUNDS; IMAGING SYSTEMS; MAGNETIC RESONANCE SPECTROSCOPY; MEDICAL IMAGING; QUALITY ASSURANCE; RADIOTHERAPY;

CLINICAL TARGET VOLUME; MULTIDIMENSIONAL CONFORMAL RADIOTHERAPY; PROSTATE CANCER; PROSTATE GLANDS;

ONCOLOGY;

FLUORODEOXYGLUCOSE F 18; IRON OXIDE;

ARTICLE; IMAGING; ISOTOPE LABELING; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER;

CELL HYPOXIA; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NANOPARTICLES; POSITRON-EMISSION TOMOGRAPHY; PROSTATE; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41749097437     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.079     Document Type: Article

References (39)

1. Pouliot J., Kim Y., Lessard E., et al. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 59 (2004) 1196-1207
2. Xia P., Pickett B., Vigneault E., et al. Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. Int J Radiat Oncol Biol Phys 51 (2001) 244-254
3. Pickett B., Vigneault E., Kurhanewicz J., et al. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 44 (1999) 921-929
4. Roach III M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
5. Roach III M., DeSilvio M., Valicenti R., et al. Whole-pelvis, "mini-pelvis", or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys 66 (2006) 647-653
6. Seaward S.A., Weinberg V., Lewis P., et al. Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 42 (1998) 1055-1062
7. Perez C.A., Michalski J., Brown K.C., et al. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 36 (1996) 573-584
8. Ploysongsang S., Aron B.S., Shehata W.M., et al. Comparison of whole pelvis versus small-field radiation therapy for carcinoma of prostate. Urology 27 (1986) 10-16
9. Cornud F., Hamida K., Flam T., et al. Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: Correlation with radical prostatectomy findings. Am J Roentgenol 175 (2000) 1161-1168
10. Lue T.F., Hricak H., Marich K.W., et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology 155 (1985) 777-781
11. Albertsen P.C., Hanley J.A., Harlan L.C., et al. The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: A population based analysis. J Urol 168 (2002) 1138-1143
12. Villers A., Puech P., Mouton D., et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: Correlation with radical prostatectomy findings. J Urol 176 (2006) 2432-2437
13. Ogura K., Maekawa S., Okubo K., et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neuro-vascular bundle involvement of prostate cancer: Correlation with histopathologic results. Urology 57 (2001) 721-726
14. Mullerad M., Hricak H., Kuroiwa K., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174 (2005) 2158-2163
15. Sella T., Schwartz L.H., Swindle P.W., et al. Suspected local recurrence after radical prostatectomy: Endorectal coil MR imaging. Radiology 231 (2004) 379-385
16. Silverman J.M., and Krebs T.L. MR imaging evaluation with a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. Am J Roentgenol 168 (1997) 379-385
17. Kurhanewicz J., Vigneron D.B., Hricak H., et al. Three dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7 cc) spatial resolution. Radiology 198 (1996) 795-805
18. Kurhanewicz J., Swanson M.G., Nelson S.J., et al. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16 (2002) 451-463
19. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
20. Costello L.C., and Franklin R.B. Concepts of citrate production and secretion by prostate. 1. Metabolic relationships. Prostate 18 (1991) 25-46
21. Payne G.S., and Leach M.O. Applications of magnetic resonance spectroscopy in radiotherapy treatment planning. Br J Radiol 79 (2006) S16-S26
22. Coakley F.V., Teh H.S., Qayyum A., et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: Preliminary experience. Radiology 233 (2004) 441-448
23. Hodgkiss R.J. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia. Anti-Cancer Drug Des 13 (1998) 687-702
24. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
25. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
26. Saleem A. Potential of PET in oncology and radiotherapy. Br J Radiol S28 (2005) 6-16
27. Effert P.J., Bares R., Handt S., et al. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 155 (1996) 994-998
28. Liu I.J., Zafar M.B., Lai Y.H., et al. Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ confined prostate cancer. Urology 57 (2001) 108-111
29. Hara T., Kosaka N., and Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 39 (1998) 990-995
30. Kotzerke J., Prang J., Neumaier B., et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 27 (2000) 1415-1419
31. de Jong I.J., Pruim J., Elsinga P.H., et al. Visualization of prostate cancer with 11C-choline positron emission tomography. Eur Urol 42 (2002) 18-23
32. de Jong I.J., Pruim J., Elsinga P.H., et al. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 44 (2003) 331-335
33. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499
34. Ross R., and Harisinghani M. New clinical imaging modalities in prostate cancer. Hematol Oncol Clin North Am 20 (2006) 811-830
35. Shih A.H., Harisinghani M.G., Zietman A.L., et al. Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys 63 (2005) 1262-1269
36. Taylor A., Rockall A.G., Reznek R.H., et al. Mapping pelvic lymph nodes: Guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1604-1612
37. Krengli M., Ballaré A., Cannillo B., et al. Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 1100-1104
38. Wawroschek F., Vogt H., Wengenmair H., et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70 (2003) 303-310
39. 18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 176 (2006) 2014-2019